サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421640

レフサム病治療市場、シェア、規模、動向、産業分析レポート：タイプ別、エンドユーザー別、年齢層別、地域別、セグメント別予測、2023年～2032年

Refsum Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Surgery and Medication); By End User (Hospitals, Clinics, Research Centers, Homecare); By Age Group; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
レフサム病治療市場、シェア、規模、動向、産業分析レポート：タイプ別、エンドユーザー別、年齢層別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のレフサム病治療市場規模は2032年までに25億5,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

遺伝性疾患や希少疾患とその利用可能な治療オプションに関する知識と意識の高まり、世界人口の急激な増加に加え、より高精度で低コストの、より強化された新しい治療オプションの開発に対する政府支援の急増と資金調達の増加は、市場成長を促進する顕著な要因の一つです。さらに、疾患のより良い理解と潜在的な治療ターゲットの開拓につながる可能性のあるレフサム病の病態生理学の研究の普及は、様々な遺伝子治療に対する政府の承認の増加とともに、世界市場を積極的に促進すると思われます。

例えば、2023年5月、Atsena Therapeutics社は、X連鎖性網膜弛緩症遺伝子治療の第1/2相臨床試験の開始について、米国食品医薬品局（FDA）から承認取得に成功したと発表しました。

遺伝子検査や分子プロファイリングの進歩は、治療への個別化アプローチを可能にし、より効果的で的を絞った介入につながる、個人の特定の遺伝子プロファイルや疾患特性に合わせた治療法の普及を拡大しており、近い将来、新たな成長の道や機会が開かれる可能性が高いです。

世界中で急増している個別化医療のアプローチは、基本的に遺伝子検査や分子プロファイリングの進歩によって個々の患者のプロファイルに合わせた治療計画を含むものであり、その結果、レフスムのような希少疾患の患者に対してより的を絞った効果的な介入が行われるようになります。

市場に参入しようとする新興企業や新規企業の数は急増しており、患者にとってより効果的かつ効率的な治療ソリューションを確保するため、研究開発に巨額の投資を行っています。また、既存の治療技術を進歩させるため、いくつかの臨床試験や医学研究に取り組んでおり、世界市場での地位を確保しようとしています。

レフサム病治療市場レポートハイライト

  • レフサム病のような希少疾患患者の間で、効果的な外科的ソリューションに対するニーズが高まっていることから、外科部門が注目すべき市場シェアを占めています。
  • 病院には高度な設備と診断技術が整っているため、病院部門が大きなシェアを占め、業界を牽引
  • 主に世界の成人人口の増加と様々な希少疾患を患う人々の増加に起因しています。
  • 北米は、確立されたヘルスケアインフラの存在と、治療オプションの利用可能性に関する認知度により、市場を独占しています。
  • 主な市場プレイヤーは、セウタ・ヘルスケア、イルミナ、ニュロトロン・バイオテクノロジー、ウィリアム・デマント・ホールディング、コクレア、バイオラッド・ラボラトリーズなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のレフサム病治療市場に関する洞察

  • レフサム病治療市場- エンドユーザーのスナップショット
  • レフサム病治療市場力学
    • 促進要因と機会
      • さまざまな希少な遺伝性疾患に関する懸念の増大
      • 医学調査と治療法の進歩
    • 抑制要因と課題
      • 高額な治療費と限られたアクセス
  • PESTEL分析
  • Refsum疾患治療市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のレフサム病治療市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 手術
  • 薬剤

第6章 世界のレフサム病治療市場、年齢層別

  • 主な調査結果
  • イントロダクション
  • 小児
  • 大人

第7章 世界のレフサム病治療市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • 研究センター
  • 在宅ケア

第8章 地域の世界のレフサム病治療市場

  • 主な調査結果
  • イントロダクション
    • レフサム病治療市場評価、地域別、2019-2032年
  • レフサム病治療市場-北米
    • 北米：レフサム病治療市場、タイプ別、2019～2032年
    • 北米：レフサム病治療市場、エンドユーザー別、2019～2032年
    • 北米：レフサム病治療市場、年齢層別、2019～2032年
    • リフサム疾患治療市場-米国
    • レフサム病治療市場- カナダ
  • レフサム病治療市場- 欧州
    • 欧州：レフサム病治療市場、タイプ別、2019～2032年
    • 欧州：レフサム病治療市場、エンドユーザー別、2019～2032年
    • 欧州：レフサム病治療市場、年齢層別、2019～2032年
    • レフサム病治療市場- 英国
    • レフサム病治療市場- フランス
    • レフサム病治療市場- ドイツ
    • レフサム病治療市場- イタリア
    • レフサム病治療市場- スペイン
    • レフサム病治療市場- オランダ
    • レフサム病治療市場- ロシア
  • レフサム病治療市場- アジア太平洋
    • アジア太平洋：レフサム病治療市場、タイプ別、2019～2032年
    • アジア太平洋：レフサム病治療市場、エンドユーザー別、2019～2032年
    • アジア太平洋：レフサム病治療市場、年齢層別、2019～2032年
    • レフサム病治療市場- 中国
    • レフサム病治療市場- インド
    • レフサム病治療市場- マレーシア
    • リフサム病治療市場- 日本
    • リフサム病治療市場- インドネシア
    • レフサム病治療市場- 韓国
  • レフサム病治療市場-中東およびアフリカ
    • 中東およびアフリカ：レフサム病治療市場、タイプ別、2019～2032年
    • 中東およびアフリカ：レフサム病治療市場、エンドユーザー別、2019～2032年
    • 中東およびアフリカ：レフサム病治療市場、年齢層別、2019～2032年
    • レフサム病治療市場- サウジアラビア
    • レフサム病治療市場- アラブ首長国連邦
    • レフサム病治療市場- イスラエル
    • リフサム病治療市場- 南アフリカ
  • レフサム病治療市場-ラテンアメリカ
    • ラテンアメリカ：レフサム病治療市場、タイプ別、2019～2032年
    • ラテンアメリカ：レフサム病治療市場、エンドユーザー別、2019～2032年
    • ラテンアメリカ：レフサム病治療市場、年齢層別、2019～2032年
    • リフサム病治療市場- メキシコ
    • レフサム病治療市場- ブラジル
    • レフサム病治療市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Agilent Technologies
  • B. Braun Medical Inc.
  • BioRad Laboratories Inc.
  • Ceuta Healthcare Limited
  • Cochlear Ltd.
  • Cook
  • Fresenius Kabi
  • Igenomix
  • Illumina Inc.
  • Medline Industries Inc.
  • Nurotron Biotechnology Co. Ltd.
  • Sequenom
  • Sonova
  • William Demant Holding A/S
図表

List of Tables

  • Table 1 Global Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 3 Global Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 4 Refsum Disease Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 7 North America: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 8 U.S.: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 10 U.S.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 11 Canada: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 13 Canada: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 14 Europe: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 16 Europe: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 17 UK: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 19 UK: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 20 France: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 22 France: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 23 Germany: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 25 Germany: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 26 Italy: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 28 Italy: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 29 Spain: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 31 Spain: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 35 Russia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 37 Russia: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 41 China: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 43 China: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 44 India: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 46 India: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 50 Japan: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 52 Japan: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 56 South Korea: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 58 South Korea: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 65 UAE: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 67 UAE: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 68 Israel: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 70 Israel: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 71 South Africa: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 73 South Africa: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 74 Latin America: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 76 Latin America: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 77 Mexico: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 79 Mexico: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 80 Brazil: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 82 Brazil: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • Table 83 Argentina: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • Table 85 Argentina: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Refsum Disease Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Age Group
  • Figure 7. Global Refsum Disease Treatment Market, by Age Group, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Refsum Disease Treatment Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Refsum Disease Treatment Market, by End User, 2022 & 2032 (USD Billion)
  • Figure 12. Refsum Disease Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Refsum Disease Treatment Market
目次
Product Code: PM3971

The global refsum disease treatment market size is expected to reach USD 2.55 billion by 2032, according to a new study by Polaris Market Research. The report "Refsum Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Surgery and Medication); By End User (Hospitals, Clinics, Research Centers, Homecare); By Age Group; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing knowledge and awareness about genetic and rare disorders and their available treatment options and the rapid increase in global population, along with the surging government support and rising funding for the development of new and more enhanced treatment options with higher accuracy and low costs, are among the prominent factors driving the market growth. Additionally, the proliferation of research into the pathophysiology of refsum disease that could lead to a better understanding of the condition and the development of potential treatment targets, along with the increase in government approvals for various gene therapies, is likely to foster the global market positively.

For instance, in May 2023, Atsena Therapeutics announced that they had successfully received authorization from the US Food and Drug Administration for the launch of their phase 1/2 clinical trial of X-linked retinoschisis gene therapy.

Growing advances in genetic testing and molecular profiling, which allow for a more personalized approach to treatment and increasing proliferation for tailoring therapies to an individual's specific genetic profile and disease characteristics that can lead to more effective and targeted interventions, are likely to open up new growth avenues and opportunities in the near future.

Surging personalized medicine approaches across the globe, which basically involve tailoring treatment plans to individual patient profiles with advancements in genetic testing and molecular profiling, results in more targeted and effective interventions for patients with rare diseases like refsum.

There has been a surge in the number of startups and new companies trying to enter the market and are investing huge amounts in R&D to ensure more effective & efficient treatment solutions for patients. They are also working on several clinical trials and medical research to provide advancements in existing treatment techniques and, thus, looking to secure their position in the global market.

Refsum Disease Treatment Market Report Highlights

  • The surgery segment accounted for noteworthy market share on account of the rising need for effective surgical solutions among patients with rare disorders like refsum
  • The hospitals segment led the industry market with a substantial share due to the presence of several advanced equipped and diagnostic techniques in hospitals
  • The adults segment will grow at the fastest rate, which is mainly attributed to the growing global adult population and the number of people suffering from different rare diseases
  • North America dominated the market on account of the presence of well-established healthcare infrastructure and awareness about the availability of treatment options
  • The key market players include Ceuta Healthcare, Illumina, Nurotron Biotechnology, William Demant Holding, Cochlear, & BioRad Laboratories

Polaris Market Research has segmented the refsum disease treatment market report based on type, end user, age group, and region:

Refsum Disease Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Surgery
  • Medication

Refsum Disease Treatment, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Research Centers
  • Homecare

Refsum Disease Treatment, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric
  • Adults

Refsum Disease Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Refsum Disease Treatment Market Insights

  • 4.1. Refsum Disease Treatment Market - End User Snapshot
  • 4.2. Refsum Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing concerns related to various rare and genetic disorders
      • 4.2.1.2. Advancements in medical research and therapeutics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs and limited accessibility
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Refsum Disease Treatment Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Refsum Disease Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Surgery
    • 5.3.1. Global Refsum Disease Treatment Market, by Surgery, by Region, 2019-2032 (USD Billion)
  • 5.4. Medication
    • 5.4.1. Global Refsum Disease Treatment Market, by Medication, by Region, 2019-2032 (USD Billion)

6. Global Refsum Disease Treatment Market, by Age Group

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • 6.3. Pediatric
    • 6.3.1. Global Refsum Disease Treatment Market, by Pediatric, by Region, 2019-2032 (USD Billion)
  • 6.4. Adults
    • 6.4.1. Global Refsum Disease Treatment Market, by Adults, by Region, 2019-2032 (USD Billion)

7. Global Refsum Disease Treatment Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Refsum Disease Treatment Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Clinics
    • 7.4.1. Global Refsum Disease Treatment Market, by Clinics, By Region, 2019-2032 (USD Billion)
  • 7.5. Research Centers
    • 7.5.1. Global Refsum Disease Treatment Market, by Research Centers, By Region, 2019-2032 (USD Billion)
  • 7.6. Homecare
    • 7.6.1. Global Refsum Disease Treatment Market, by Homecare, By Region, 2019-2032 (USD Billion)

8. Global Refsum Disease Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Refsum Disease Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Refsum Disease Treatment Market - North America
    • 8.3.1. North America: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.3.3. North America: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.3.4. Refsum Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.3.5. Refsum Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • 8.4. Refsum Disease Treatment Market - Europe
    • 8.4.1. Europe: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.4. Refsum Disease Treatment Market - UK
      • 8.4.4.1. UK: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.5. Refsum Disease Treatment Market - France
      • 8.4.5.1. France: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.6. Refsum Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.7. Refsum Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.8. Refsum Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.9. Refsum Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.4.10. Refsum Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • 8.5. Refsum Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.4. Refsum Disease Treatment Market - China
      • 8.5.4.1. China: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.5. Refsum Disease Treatment Market - India
      • 8.5.5.1. India: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.6. Refsum Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.7. Refsum Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.8. Refsum Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.5.9. Refsum Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • 8.6. Refsum Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.6.4. Refsum Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.6.5. Refsum Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.6.6. Refsum Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.6.7. Refsum Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
  • 8.7. Refsum Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.7.4. Refsum Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.7.5. Refsum Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)
    • 8.7.6. Refsum Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Refsum Disease Treatment Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Refsum Disease Treatment Market, by End User, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Refsum Disease Treatment Market, by Age Group, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Agilent Technologies
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. B. Braun Medical Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BioRad Laboratories Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ceuta Healthcare Limited
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cochlear Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cook
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Fresenius Kabi
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Igenomix
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Illumina Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Medline Industries Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Nurotron Biotechnology Co. Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sequenom
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sonova
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. William Demant Holding A/S
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development